GoodRx Holdings Inc (GDRX)
8.055
+0.78
(+10.80%)
USD |
NASDAQ |
May 16, 16:00
8.055
0.00 (0.00%)
After-Hours: 20:00
GoodRx Holdings Cash from Operations (TTM): 148.59M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 148.59M |
December 31, 2023 | 138.29M |
September 30, 2023 | 154.30M |
June 30, 2023 | 127.76M |
March 31, 2023 | 148.95M |
December 31, 2022 | 146.78M |
September 30, 2022 | 164.71M |
Date | Value |
---|---|
June 30, 2022 | 179.54M |
March 31, 2022 | 163.41M |
December 31, 2021 | 178.78M |
September 30, 2021 | 143.82M |
June 30, 2021 | 127.93M |
March 31, 2021 | 131.23M |
December 31, 2020 | 131.34M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
127.76M
Minimum
Jun 2023
179.54M
Maximum
Jun 2022
148.96M
Average
147.68M
Median
Cash from Operations (TTM) Benchmarks
Sharecare Inc | -10.07M |
American Well Corp | -178.95M |
MultiPlan Corp | 157.22M |
Privia Health Group Inc | 61.03M |
GeneDx Holdings Corp | -141.00M |